Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients
Information source: Western Galilee Hospital-Nahariya
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pain Relief
Intervention: Diclofenac hydroxyethylpyrrolidine (Drug); orphenadrine (Drug); Tramadol (Drug); Dipyrone (Drug)
Phase: N/A
Status: Not yet recruiting
Sponsored by: Western Galilee Hospital-Nahariya Official(s) and/or principal investigator(s): Nimrod Rahamimov, M.D., Principal Investigator, Affiliation: Western Galilee Hospital
Summary
The investigators will conduct a randomized double blind study, to determine whether patient
analgesic delivery mode preference affects pain reduction quality in non-surgical spine
patients.
The patients will receive both intra-muscular and oral non-narcotic analgesics and placebo.
During the study period, pain reduction parameters will be collected. At the end of the
study period, the investigators will attempt to find a correlation between pre-study patient
preferences and the quality of the pain reduction achieved.
Clinical Details
Official title: The Relationship Between Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: pain scores on visual analog scale
Secondary outcome: Patient Questionnaire assessing pain and pain reliefpatient preference Questionnaire
Eligibility
Minimum age: 15 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients with chronic and acute back pain
Exclusion Criteria:
- Recent Spine Surgery
Locations and Contacts
Western Galilee Hospital, Naharia, Israel; Not yet recruiting Adi H Shani, R.N. , BA, Phone: +97249107200, Email: a_eilat@walla.com Nimrod Rahamimov, M.D., Phone: +972507887564, Email: nimrod.rahamimov@naharia.health.gov.il Nimrod Rahamimov, M.D., Principal Investigator
Additional Information
Starting date: December 2010
Last updated: December 16, 2010
|